# FDA Inspection 1291150 - StemCyte, Inc - March 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/stemcyte-inc/fe5f8458-e932-47ff-a32a-9ff2060b47b0
Source feed: FDA_Inspections

> FDA Inspection 1291150 for StemCyte, Inc on March 24, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291150
- Company Name: StemCyte, Inc
- Inspection Date: 2026-03-24
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1101775 - 2019-07-31](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/1b4c492c-9c4f-40a2-96b6-51cb0b279380)
- [FDA Inspection 821099 - 2013-03-12](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/9e207d14-46c2-4b4c-88d8-ef7c1db86ae9)
- [FDA Inspection 736757 - 2011-07-28](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/b7f1e527-9157-4bb1-878b-1049c3348c1e)
- [FDA Inspection 643295 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/2097e50c-919e-462b-86be-7efda227177e)

Company: https://www.keypedia.com/companies/stemcyte-inc/8d9f9d48-8d24-4ba3-8af0-707de0bb4595

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b